Entering the post-approval phase marks a critical pivot for pharmaceutical companies, shifting their focus from the ...

At its core, the regulation aims to improve transparency and accountability in clinical trials across Europe. For ...

Dr Michalis Papadakis, CEO and Co-Founder of Brainomix, highlighted the shared vision of both companies: “This partnership ...

To help HCPs find reliable online answers about medicines, Datapharm collaborated with Medical Information Leaders in Europe ...

Alligator Bioscience has announced updated results from its phase 2 OPTIMIZE-1 study, showing the survival benefits of ...

In a world of multiplying data and discourse, stakeholders across life sciences and healthcare are increasingly struggling to ...

Major medical advances, combined with the proliferation of new technologies, have created opportunities for biopharmaceutical ...

Microbiotica, a clinical-stage biopharma company, has presented new data on MB097 at the AACR IO meeting held in Los Angeles.

“Our 10 Year Health Plan will deliver the three big shifts our NHS needs to be fit for the future – from hospital to ...

With healthcare systems around the world facing unprecedented challenges, now more than ever, there is a need for new, ...

Broadly defined as excess weight that puts an individual at higher risk for adverse health outcomes, obesity is associated ...

From a patient’s perspective, the outcome of using the NHS is predominantly some form of medication.